Hanger, Inc. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2020-11-04: Form 8-K; Period of report 2020-11-04; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2020-10-14: Form 8-K; Period of report 2020-10-14; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2020-10-01: Form 8-K; Period of report 2020-10-01; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2020-09-24: Form 8-K; Period of report 2020-09-24; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2020-11-04 | 8-K | 2020-11-04 | 2.02 Results of Operations and Financial Condition | 2.02 On November 4, 2020, Hanger, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the three and nine months ended September 30, 2020. | tm2034901d1_8k.htm |
| 2020-10-14 | 8-K | 2020-10-14 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Hanger, Inc. (the “Company”) today announced that, effective November 2, 2020, Peter A. Stoy, has been appointed Executive Vice President and Chief Operating Officer of the Company and will lead the Patient Care segment, along with the supply chain and mergers & acquisitions functions. | tm2033031-1_8k.htm |
| 2020-10-01 | 8-K | 2020-10-01 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Hanger, Inc. (the “Company”) has announced that Samuel M. Liang, President of Hanger Clinic, will be leaving the employment of the Company on November 13, 2020. | tm2032075d1_8k.htm |
| 2020-09-24 | 8-K | 2020-09-24 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Hanger, Inc. (the “Company”) announced that on September 24, 2020 the Company’s Board of Directors (the “Board”) elected Mark M. Jones, M.D. as a director of the Company to serve until the 2021 annual meeting of stockholders of the Company and until his successor is elected and qualified. | tm2031554-1_8k.htm |
| 2020-09-10 | 8-K | 2020-09-10 | 8.01 Other Events | 8.01 On September 10, 2020, Hanger, Inc. (the “Company”) filed a Shelf Registration Statement on Form S-3 (the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”) to register securities for future issuance as part of a shelf registration. | tm2030318-3_8k.htm |
| 2020-08-05 | 8-K | 2020-08-05 | 2.02 Results of Operations and Financial Condition; 8.01 Other Events | 2.02 On August 5, 2020, Hanger, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the three and six months ended June 30, 2020. 8.01 On March 31, 2020, the Company announced that all members of its senior leadership team, including all of the Company’s named executive officers, had agreed to forego base salary in varying percentages during the period commencing on April 4, 2020 and concluding on or before October 2, 2020 (the “Reduction Period”) as a part of the Company’s efforts to mitigate the financial impact of the COVID-19 pandemic on the Company. | tm2026466-1_8k.htm |
| 2020-06-08 | 8-K | 2020-06-08 | 8.01 Other Events | 8.01 As previously disclosed, in April 2020, Hanger, Inc. (the “Company”) experienced a decline in day- adjusted patient appointment volumes in its Patient Care clinics of approximately 40% as compared to the same period in 2019. | tm2021888d1_8k.htm |
| 2020-05-19 | 8-K | 2020-05-13 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders | 5.02 In May 2017, the Compensation Committee of the Board of Directors of Hanger, Inc. (the “Company”) adopted the Company’s Special Equity Plan and made a special one-time equity grant to certain key employees, including each of the Company’s named executive officers, for both recognition and retention purposes. 5.07 At the Annual Meeting of Stockholders of the Company held on May 14, 2020 (the “Annual Meeting”), the Company's stockholders voted on three proposals as set forth below. | tm2019999-2_8k.htm |
| 2020-05-18 | 8-K | 2020-05-18 | 7.01 Regulation FD Disclosure | 7.01 Beginning May 19, 2020, Hanger, Inc. (the “Company”), as part of its ongoing support, outreach and communications with the financial community, will make available an investor presentation published to the Investors Relations page of the Company’s website at https://investor.hanger.com. | tm2019999d1_8k.htm |
| 2020-05-07 | 8-K | 2020-05-04 | 1.01 Entry into a Material Definitive Agreement; 2.02 Results of Operations and Financial Condition | 1.01 Entry into a Material Definitive Agreement. 2.02 On May 7, 2020, the Company issued a press release announcing the Company’s financial results for the three months ended March 31, 2020. | tm2018764d1_8k.htm |
| 2020-03-31 | 8-K | 2020-03-31 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 31, 2020, Hanger, Inc. (the “Company”) announced that all members of its senior leadership team, including all of the Company’s named executive officers, had agreed to forego base salary in varying percentages during the period from April 4, 2020 up to, but not exceeding October 2, 2020 (the “Reduction Period”) as a part of the Company’s efforts to mitigate the financial impact of the COVID-19 pandemic on the Company. | tm2014269-1_8k.htm |
| 2020-03-24 | 8-K | 2020-03-24 | 7.01 Regulation FD Disclosure | 7.01 Hanger, Inc. (the “Company”) announced today that it expects to experience a near-term reduction in patient appointment volumes in its clinics due to the effects of the COVID-19 pandemic and the related quarantine and social activity cessation measures being implemented by Federal, State and local authorities to respond to and suppress the virus. | tm2013633-1_8k.htm |
| 2020-03-11 | 8-K | 2020-03-11 | 2.02 Results of Operations and Financial Condition | 2.02 On March 11, 2020, Hanger, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the fourth quarter and year ended December 31, 2019. | tm2012164d1_8k.htm |
| 2020-01-24 | 8-K | 2020-01-24 | 8.01 Other Events | 8.01 On January 24, 2020, Hanger, Inc. (the “Company”) announced that the Company, in its capacity as a nominal defendant, entered into a Stipulation and Agreement of Settlement (“Stipulation”) in the shareholder derivative action filed in the 345th Judicial District Court in Travis County, Texas, Judy v. | tm205763-1_8k.htm |